Travere Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Travere Therapeutics, Inc.‘s stocks are currently a part of 95 hedge funds’ portfolios, which represents 43.91% of the total amount of its stocks outstanding. This makes up a total of 27.99M shares of Travere Therapeutics, Inc.. Compared to the previous quarter, the number fell by -61.63% or -44.97M shares fewer. As for the holding position changes, 48.42% (46) of current hedge fund investors increased the number of shares held, 15.79% (15) of current holders sold a part of the shares held, and 7.37% (7) closed the holdings completely. 19 hedge funds are new holders of Travere Therapeutics, Inc. stock in Q1 2023, it is 20% of total holders.
Hedge funds holding Travere Therapeutics (Q4 2020 – Q1 2023)
| Q4 2020 | 136 |
|---|---|
| Q1 2021 | 147 |
| Q2 2021 | 133 |
| Q3 2021 | 145 |
| Q4 2021 | 168 |
| Q1 2022 | 166 |
| Q2 2022 | 165 |
| Q3 2022 | 166 |
| Q4 2022 | 153 |
| Q1 2023 | 95 |
Hedge funds changes in Travere Therapeutics positions (Q4 2020 – Q1 2023)
| Q4 2020 | 136 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2021 | 36 | 57 | 37 | 23 | -6 |
| Q2 2021 | 22 | 49 | 42 | 36 | -16 |
| Q3 2021 | 33 | 43 | 53 | 20 | -4 |
| Q4 2021 | 40 | 50 | 50 | 16 | 12 |
| Q1 2022 | 22 | 62 | 58 | 23 | 1 |
| Q2 2022 | 21 | 55 | 66 | 19 | 4 |
| Q3 2022 | 23 | 61 | 54 | 22 | 6 |
| Q4 2022 | 15 | 71 | 53 | 25 | -11 |
| Q1 2023 | 19 | 46 | 15 | 7 | 8 |
Hedge funds changes in Travere Therapeutics stock options (Q4 2020 – Q1 2023)
| Q4 2020 | 3,514,000 | 4,492,000 |
|---|---|---|
| Q1 2021 | 3,071,000 | 2,761,000 |
| Q2 2021 | 2,426,000 | 1,994,000 |
| Q3 2021 | 6,192,000 | 5,084,000 |
| Q4 2021 | 5,271,000 | 5,264,000 |
| Q1 2022 | 4,431,000 | 2,553,000 |
| Q2 2022 | 4,139,000 | 1,905,000 |
| Q3 2022 | 9,190,000 | 2,441,000 |
| Q4 2022 | 1,357,757 | 1,133,414 |
| Q1 2023 | 137,348,000 | 499,607,000 |